{"nct_id":"NCT03463525","title":"Open-label PET Study With [11C]Osimertinib in Patients With EGFRm NSCLC and Brain Metastases","status":"COMPLETED","status_verified_date":"2022-04","start_date":"2018-10-24","start_date_type":"ACTUAL","primary_completion_date":"2020-03-19","primary_completion_date_type":"ACTUAL","completion_date":"2020-10-05","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["AZN"]}